Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer.

被引：0
|
作者：
Schoen, Martin W.
Carson, Kenneth Robert
Luo, Suhong
Eisen, Seth
Reimers, Melissa Andrea
Drake, Bettina F.
Bennett, Charles L.
Knoche, Eric Marshall
Yan, Yan
Sanfilippo, Kristen Marie
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] St Louis Vet Affairs Med Ctr, Res Serv, St Louis, MO USA
[3] St Louis Vet Affairs Med Ctr, St Louis, MO USA
[4] Washington Univ, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Med, Div Med Oncol, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[7] South Carolina Coll Pharm, Columbia, SC USA
[8] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO USA
[9] Washington Univ, Barnes & Jewish Hosp, St Louis, MO 63110 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5032
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
    Rana, Dikshyanta
    Geue, Claudia
    Baillie, Kelly
    Pan, Jiafeng
    Mueller, Tanja
    Laskey, Jennifer
    Bennie, Marion
    Clarke, Julie
    Jones, Robert J.
    Brown, Ailsa
    Wu, Olivia
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 303 - 313
  • [32] Central nervous system conditions in abiraterone or enzalutamide-treated prostate cancer patients.
    Pilon, Dominic
    Ellis, Lorie
    McKenzie, R. Scott
    Gozalo, Laurence
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer
    Lai, Lillian Y.
    Kaufman, Samuel R.
    Oerline, Mary K.
    Caram, Megan E., V
    Maganty, Avinash
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    JNCI CANCER SPECTRUM, 2022, 6 (02)
  • [34] Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
    Dikshyanta Rana
    Claudia Geue
    Kelly Baillie
    Jiafeng Pan
    Tanja Mueller
    Jennifer Laskey
    Marion Bennie
    Julie Clarke
    Robert J. Jones
    Ailsa Brown
    Olivia Wu
    PharmacoEconomics - Open, 2022, 6 : 303 - 313
  • [35] RISK OF METABOLIC AND CARDIOVASCULAR ADVERSE EVENTS WITH ABIRATERONE OR ENZALUTAMIDE AMONG MEN WITH ADVANCED PROSTATE CANCER
    Lai, Lillian
    Oerline, Mary
    Caram, Megan
    Tsao, Phoebe
    Kaufman, Samuel
    Hollenbeck, Brent
    Shahinian, Vahakn
    JOURNAL OF UROLOGY, 2022, 207 (05): : E828 - E829
  • [36] Early national dissemination of abiraterone and enzalutamide for advanced prostate cancer in Medicare Part D.
    Caram, Megan Veresh
    Borza, Tudor
    Min, Hye-Sung
    Griggs, Jennifer J.
    Miller, David Christopher
    Hollenbeck, Brent K.
    Mukherjee, Bhramar
    Skolarus, Ted A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [37] Antitumor activity of abiraterone, enzalutamide, and docetaxel following treatment with diethystilbestrol in castration-resistant prostate cancer.
    Assoun, Sandra
    Campedel, Luca
    Roupret, Morgan
    Vaessen, Christophe
    Parra, Jerome
    Boostandoost, Haide Angele
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [38] Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer
    Lai, Lillian Y.
    Oerline, Mary K.
    Caram, Megan E., V
    Tsao, Phoebe A.
    Kaufman, Samuel R.
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (08): : 1127 - 1134
  • [39] Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer
    Daniel J. George
    Krishnan Ramaswamy
    Ahong Huang
    David Russell
    Jack Mardekian
    Neil M. Schultz
    Nora Janjan
    Stephen J. Freedland
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 524 - 530
  • [40] THE CARDIOVASCULAR EFFECT OF ABIRATERONE AND ENZALUTAMIDE AMONG VETERANS AFFAIRS' METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS
    Baser, O.
    Baser, E.
    Samayoa, G.
    VALUE IN HEALTH, 2024, 27 (06) : S4 - S4
12345